Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» MHRA
MHRA
MHRA raises concerns with switching between long-acting J&J, Novartis and Takeda ADHD drugs
Fierce Pharma
Tue, 09/27/22 - 10:37 am
Takeda
JNJ
Novartis
ADHD
MHRA
Concerta XL
Ritalin XL
Equasym XL
180 Life Sciences Provides Update on Correspondence Received from U.K. and U.S. Regulatory Authorities on Pathway for a Therapy That Could Prevent Progression of Early-Stage Dupuytren’s Disease
BioSpace
Tue, 06/14/22 - 09:00 pm
180 Life Sciencs
FDA
MHRA
Dupuytren's Contracture
Dupuytren's disease
adalimumab
MHRA okays GSK’s Xevudy as data suggest it works against Omicron
Pharmaforum
Thu, 12/2/21 - 10:51 am
GSK
UK
MHRA
Xevudy
Vir Biotechnology
COVID-19
Omicron COVID-19 variant
Pfizer-BioNTech Covid-19 vaccine receives UK approval for children
Pharmaceutical Business Review
Mon, 06/7/21 - 11:04 am
Pfizer
BioNTech
vaccines
COVID-19
MHRA
pediatric
teens
Emergency Use Authorization
MHRA kicks off new accelerated drug approval pathway with ‘innovation passports’
Endpoints
Mon, 04/5/21 - 02:49 pm
UK
MHRA
innovation
accelerated approvals
Redx gets regulatory nod to restart RXC004 clinical trial
Pharmaceutical Business Review
Wed, 01/23/19 - 09:24 am
Redx
MHRA
RXC004
clinical trials
solid tumors
Alnylam seeks MHRA approval to start ALN-AAT02 phase 1/2 trial
Pharmaceutical Business Review
Thu, 10/4/18 - 06:55 pm
Alnylam
RNAi
ALN-AAT02
MHRA
UK
MHRA and Novartis lead consortium to develop adverse drug reaction app
In-Pharma Technologist
Tue, 09/9/14 - 10:18 am
Novartis
MHRA
mobile apps
adverse events